SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-101079
Filing Date
2024-09-19
Accepted
2024-09-19 06:15:40
Documents
5
Effectiveness Date
2024-09-19

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2424164d1_s8.htm S-8 48572
2 EXHIBIT 5.1 tm2424164d1_ex5-1.htm EX-5.1 6839
3 EXHIBIT 23.1 tm2424164d1_ex23-1.htm EX-23.1 2146
4 EX-FILING FEES tm2424164d1_ex-filingfees.htm EX-FILING FEES 12769
5 GRAPHIC tm2424164d1_ex5-1img002.jpg GRAPHIC 13904
  Complete submission text file 0001104659-24-101079.txt   90693
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

IRS No.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-282205 | Film No.: 241309044
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)